S.R. One

Board Description

venture capital arm of GlaxoSmithKline. The firm invests globally in emerging life science companies that are pursuing innovative science which will significantly impact medical care.

Industry
Venture Capital & Private Equity
Country
United Kingdom
State
Non USA
Board Type
Stock Market
N/A
Stock Ticker
N/A